Agiomix logo — Next Generation Diagnostics

Agiomix

Next Generation Diagnostics

Founded 2018 United Arab Emirates United Arab Emirates 43 employees Health Care

General Information

Company Name Agiomix
Founded Year 2018
Location United Arab Emirates United Arab Emirates
Employees 43
Industries Health Care
Social

BounceWatch is an independent company data service, not affiliated with Agiomix. To contact Agiomix, visit agiomix.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Agiomix compare?

A PDF of Agiomix and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Agiomix soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Agiomix

Agiomix is a molecular and genetics laboratory based in Dubai, equipped with advanced Next Generation Sequencing and Microarray instrumentation, high throughput Molecular Diagnostics sample processing, and conventional immunology, chemistry, and hematology platforms. The company offers comprehensive genetic and molecular assay analysis services, as well as conventional laboratory diagnostics with strict quality control measures and local and international certifications. Founded in 2018, Agiomix's mission is to make quality genomics and molecular testing readily available and affordable across emerging markets. Their services include routines tests and specialty tests, catering to a diverse range of diagnostic needs. Although specific information about their latest investment is not available, Agiomix presents a promising opportunity for venture capitalists looking to invest in the next generation diagnostics industry.

Business keywords: Molecular Diagnostics, Genetic Testing, Next Generation Sequencing, Microarray, Bioinformatics, Genomics, RNA Sequencing, Genotyping, Metagenomics, Whole Genome Sequencing, Quality Control, Laboratory Diagnostics, Emerging markets, Consumer Genetics

No funding data available for Agiomix yet.

Agiomix Alternatives & Competitors

View All Alternatives
Agiomix vs

Reproductive Genetics | Oncogenetics | Metabolic Genetics | e-Genetic Counseling & Consultation

345 employees
Health Care, Health and Wellness
Agiomix vs

Better Healthcare Through Next Generation Diagnostics

Venture round
56 employees
Biotechnology, Health Care
Agiomix vs
Macrogen Europe
Macrogen Europe The Netherlands

Committed to Sequencing Excellence

71 employees
Biotechnology, Health Care

FAQ About Agiomix

Next Generation Diagnostics
Agiomix was founded in 2018.
Agiomix is headquartered in United Arab Emirates.
Agiomix operates in Health Care. Its work centres on Molecular Diagnostics, Genetic Testing, Next Generation Sequencing and Microarray.
Agiomix has approximately 43 employees.
Top alternatives and competitors to Agiomix include Lilac Insights, GenePath Diagnostics, Macrogen Europe, Malaysian Genomics Resource Centre Berhad, CGC Genetics / CGC Centro Genetica Clinica. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Agiomix and Lilac Insights are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Agiomix, https://bouncewatch.com/company/agiomix, updated 6 January 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes